Osaic Holdings’s Context Therapeutics CNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding CNTX
Osaic Holdings's CNTX Position: Q3 2026 in Review
Osaic Holdings reduced its Context Therapeutics (CNTX) stake by 0.05% in Q3 2026, selling an estimated $2 and leaving 10,495 shares worth $3.35K. The position accounts for ﹤0.01% of the portfolio, ranked #7148.
Osaic Holdings first reported a position in CNTX in Q2 2023 and has held it in 14 quarters since. The position peaked at $37.5K in Q4 2025. 85 funds tracked by Wall St. Rank hold CNTX as of Q3 2026.
- Osaic Holdings held 10,495 shares of Context Therapeutics worth $3.35K as of Q3 2026.
- Osaic Holdings sold 5 Context Therapeutics shares in Q3 2026, an estimated $2.
- Context Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7148 holding.
- Osaic Holdings first reported a position in Context Therapeutics in Q2 2023 and has held it in 14 quarters since.
- Osaic Holdings's Context Therapeutics position peaked at $37.5K in Q4 2025.
- 85 funds tracked by Wall St. Rank held Context Therapeutics as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.